NCT02606864View on ClinicalTrials.gov

Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

August 31, 2016

Conditions
Chagas Disease
Interventions
DRUG

Nifurtimox (BAYa2502)

Oral Intake of 4 x 30 mg nifurtimox tablets

Trial Locations (1)

C1425BAB

Buenos Aires

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT02606864 - Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients | Biotech Hunter | Biotech Hunter